Acute Coronary Syndrome
Acute Coronary Syndrome (ACS) is a condition characterized by a sudden reduction or blockage of blood flow in the coronary arteries, leading to heart muscle damage or dysfunction; it typically presents with centrally located chest pain, often radiating to the left shoulder or jaw and accompanied by nausea and sweating, though symptoms can vary, especially in women, older adults, and individuals with diabetes. Common manifestations of ACS include heart attacks (myocardial infarction) and chest pain (angina).
Health Outcomes
- Changed QT Interval Length
- Improved Cardiac Muscle Contractile Performance
- Improved Cardiovascular Function
- Improved Event-Free Survival
- Improved Hospital Discharge
- Improved Left Ventricular Ejection Fraction
- Improved Left Ventricular Global Longitudinal Strain
- Improved Myocardial Strain Rate
- Improved Perceived Recovery
- Improved Post-Myocardial Infarction Outcome
- Improved Prognosis After Bacteremia Recovery
- Improved Survival at 24 Months
- Increased Days Alive and Out of Hospital
- Increased Endothelial Progenitor Cell Count
- Increased Mortality
- Mitigated Cardiac Injury from Myocardial Infarction
- No Change in Major Cardiovascular Event
- No Difference in Adverse Events
- No Long-Term Impact on Gut Microbiota
- Normal Safety Parameters
- Reduced Acute Kidney Injury
- Reduced Aortic Pressure
- Reduced Apolipoprotein B-100 to Apolipoprotein A-1 Ratio
- Reduced Atherosclerotic Plaque Formation
- Reduced Cardiac Arrest Risk
- Reduced Cardiac Event
- Reduced Cardiac Function
- Reduced Cardiovascular Event
- Reduced Chest Pain
- Reduced Contrast-Induced Acute Kidney Injury
- Reduced HMG-CoA Reductase Inhibition
- Reduced Hospital Mortality Rate
- Reduced Hospital Readmission Risk
- Reduced Hospital Stay
- Reduced Hospitalization Duration
- Reduced Hospitalization Rate
- Reduced In-hospital Mortality
- Reduced Inotropic Support Requirement
- Reduced Left Ventricular Ejection Fraction Decline
- Reduced Length of Hospitalization
- Reduced Length of Stay
- Reduced Mortality Rate Before Discharge
- Reduced Mortality Rate under Stress
- Reduced Myeloperoxidase Levels
- Reduced Myocardial Infarct Size
- Reduced Myocardial Injury
- Reduced Myocardial Injury Cytokines
- Reduced Organ Failure Severity
- Reduced Platelet Function Marker Level
- Reduced Pulse Rate
- Reduced Serum Amyloid A Levels
- Reduced Short-term Mortality
- Reduced Survival Rate
- Reduced Thrombosis
- Reduced Thromboxane A2 Level
- Reduced Time to Crisis Resolution